tert-butyl (S)-4-((1R,2S,3R)-1-(benzyloxy)-2,3,4-trihydroxybutyl)-2,2-dimethyloxazolidine-3-carboxylate | 1215208-02-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: tert-butyl (S)-4-((1R,2S,3R)-1-(benzyloxy)-2,3,4-trihydroxybutyl)-2,2-dimethyloxazolidine-3-carboxylate
• CAS: 1215208-02-8
• 化学式: C₂₁H₃₃NO₇
• 分子量: 411.496
• InChiKey: ZYIFNLYTGBRCQQ-XWTMOSNGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.66
• 重原子数：
  29.0
• 可旋转键数：
  7.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  108.69
• 氢给体数：
  3.0
• 氢受体数：
  7.0

反应信息

• 作为反应物：
  描述：

  tert-butyl (S)-4-((1R,2S,3R)-1-(benzyloxy)-2,3,4-trihydroxybutyl)-2,2-dimethyloxazolidine-3-carboxylate 、 甲基磺酰氯 在 2,4,6-三甲基吡啶 作用下， 以 二氯甲烷 为溶剂， 反应 4.0h， 以89%的产率得到tert-butyl (S)-4-((1R,2S,3R)-1-(benzyloxy)-2,3-dihydroxy-4-(methylsulfonyloxy)butyl)-2,2-dimethyloxazolidine-3-carboxylate
  参考文献：
  名称：

  Short and Straightforward Synthesis of (−)-1-Deoxygalactonojirimycin

  摘要：

  The mildness and low basicity of vinylzinc species functioning as a nucleophile in addition to alpha-chiral aldehydes is characterized by lack of epimerization of the vulnerable stereogenic center. This is demonstrated by a highly diastereoselective synthesis of 1-deoxygalactonojirimycin in eight steps from commercial starting materials with overall yield of 35%.

  DOI：

  10.1021/ol100037c
• 作为产物：
  描述：

  tert-butyl (S)-4-((1R,2S,3R)-1-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-2,3-dihydroxybutyl)-2,2-dimethyloxazolidine-3-carboxylate 在 四丁基氟化铵 作用下， 以 四氢呋喃 为溶剂， 反应 0.25h， 以95%的产率得到tert-butyl (S)-4-((1R,2S,3R)-1-(benzyloxy)-2,3,4-trihydroxybutyl)-2,2-dimethyloxazolidine-3-carboxylate
  参考文献：
  名称：

  Short and Straightforward Synthesis of (−)-1-Deoxygalactonojirimycin

  摘要：

  The mildness and low basicity of vinylzinc species functioning as a nucleophile in addition to alpha-chiral aldehydes is characterized by lack of epimerization of the vulnerable stereogenic center. This is demonstrated by a highly diastereoselective synthesis of 1-deoxygalactonojirimycin in eight steps from commercial starting materials with overall yield of 35%.

  DOI：

  10.1021/ol100037c